Literature DB >> 29975952

Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.

Nerina Denaro, Elvio Grazioso Russi, Marco Carlo Merlano.   

Abstract

The TNM classification is a worldwide standard staging system used to define the extent of cancer and is a major prognostic factor in predicting the outcome of patients. The TNM Classification of Malignant Tumours, 8th edition, has been used since January 1, 2018. In the area of head and neck cancer major modifications were produced: important updated T and N modification for oral cavity and nasopharyngeal cancer, the introduction of clinical and pathological stages for neck disease, and a new HPV-16-positive HNSCC classification. While until a few years ago the TNM staging system classified prognostic risk groups based on tumour size, the 8th edition responds to the need to categorize the prognosis of patients with similarly sized tumours but with very different clinical and biological behaviour. This review details TNM changes and the clinical need for these modifications, valuating possible limits in daily applicability.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Eighth edition; Head and neck squamous cell carcinoma; Human papillomavirus; Neck classification; Oral cavity; TNM staging

Mesh:

Year:  2018        PMID: 29975952     DOI: 10.1159/000490415

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  10 in total

1.  Analysis of gene co‑expression network reveals prognostic significance of CNFN in patients with head and neck cancer.

Authors:  Baoling Liu; Guanhong Huang; Hongming Zhu; Zhaoming Ma; Xiaokang Tian; Li Yin; Xingya Gao; Xia He
Journal:  Oncol Rep       Date:  2019-02-18       Impact factor: 3.906

2.  Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.

Authors:  Vanessa Milani; Ana Laura de Sene Amâncio Zara; Everton Nunes da Silva; Larissa Barbosa Cardoso; Maria Paula Curado; Rejane Faria Ribeiro-Rotta
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

3.  Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma.

Authors:  ShiChao Wang; HuanMin Zhou; RuiJian Zhang; YanRu Zhang
Journal:  Int J Gen Med       Date:  2021-11-16

4.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

5.  MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.

Authors:  Wei Zhang; Xinghong Huang; Rong Huang; Hong Zhu; Pu Ye; Xuyang Lin; Shuangyue Zhang; Meng Wu; Feng Jiang
Journal:  Comput Math Methods Med       Date:  2022-09-05       Impact factor: 2.809

6.  Prognostic significance of E-Cadherin, β-Catenin and cyclin D1 in oral squamous cell carcinoma: a tissue microarray study.

Authors:  Natheer Al-Rawi; Muwaffaq Al Ani; Asif Quadri; Zaid Hamdoon; Aktham Awwad; Sausan Al Kawas; Ahmed Al Nuaimi
Journal:  Histol Histopathol       Date:  2021-07-26       Impact factor: 2.303

Review 7.  The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma.

Authors:  Dong Ye; Yongqin Deng; Zhisen Shen
Journal:  Onco Targets Ther       Date:  2021-07-08       Impact factor: 4.147

8.  Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT.

Authors:  Zheran Liu; Yuan Cao; Wei Diao; Yue Cheng; Zhiyun Jia; Xingchen Peng
Journal:  Aging (Albany NY)       Date:  2020-07-16       Impact factor: 5.682

9.  HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.

Authors:  Xiang Wu; Jin Li; Tingyuan Yan; Xueping Ke; Xin Li; Yumin Zhu; Jianrong Yang; Zhongwu Li
Journal:  Cancer Cell Int       Date:  2021-07-24       Impact factor: 5.722

Review 10.  Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

Authors:  Alhadi Almangush; Stijn De Keukeleire; Sylvie Rottey; Liesbeth Ferdinande; Tijl Vermassen; Ilmo Leivo; Antti A Mäkitie
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.